HCA Healthcare, Inc. (HCA) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
HCA Healthcare’s revenue went from $41.5B in fiscal 2016 to $75.6B in fiscal 2025, growth of about 6.9% a year.
Net income in fiscal 2025 was $6.8B, a net margin of 9.0%; the best year in this period was 2021 with $7.0B.
Over the twelve months to September 30, 2026, revenue was $78.7B and net income $6.8B.
Free cash flow was $7.7B in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count fell 39% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $78.7B | $75.6B | $70.6B | $65.0B | $60.2B | $58.8B | $51.5B | $51.3B | $46.7B | $43.6B | $41.5B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | $12.2B | $9.8B | $8.5B | $7.7B | $8.6B | $9.8B | $5.4B | $5.2B | $5.3B | $4.4B | $4.8B |
| Net income | $6.8B | $6.8B | $5.8B | $5.2B | $5.6B | $7.0B | $3.8B | $3.5B | $3.8B | $2.2B | $2.9B |
| EPS (diluted) | $30.14 | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 | $5.95 | $7.30 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +7.1% | +8.7% | +7.9% | +2.5% | +14.0% | +0.4% | +10.0% | +7.0% | +5.1% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $11.2B | $12.6B | $10.5B | $9.4B | $8.5B | $9.0B | $9.2B | $7.6B | $6.8B | $5.4B | $5.7B |
| Capital spending | -$5.2B | -$4.9B | -$4.9B | -$4.7B | -$4.4B | -$3.6B | -$2.8B | -$4.2B | -$3.6B | -$3.0B | -$2.8B |
| Free cash flow | $6.0B | $7.7B | $5.6B | $4.7B | $4.1B | $5.4B | $6.4B | $3.4B | $3.2B | $2.4B | $2.9B |
| Dividends paid | $681M | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | — |
| Buybacks | $9.2B | $10.1B | $6.0B | $3.8B | $7.0B | $8.2B | $441M | $1.0B | $1.5B | $2.1B | $2.8B |
| Stock-based pay | $404M | $401M | $360M | $262M | $341M | $440M | $362M | $347M | $268M | $270M | $251M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $1.0B | $1.9B | $935M | $908M | $1.6B | $1.9B | $621M | $502M | $732M | $646M |
| Debt | — | $48.7B | $45.2B | $41.9B | $40.2B | $36.7B | $33.1B | $35.6B | $32.8B | $33.1B | $31.4B |
| Equity | — | -$6.0B | -$2.5B | -$1.8B | -$2.8B | -$933M | $572M | -$2.8B | -$5.0B | -$6.8B | -$7.3B |
| Total assets | — | $60.7B | $59.5B | $56.2B | $52.4B | $50.7B | $47.5B | $45.1B | $39.2B | $36.6B | $33.8B |
| Shares (diluted) | 217M | 239M | 262M | 276M | 295M | 329M | 344M | 348M | 355M | 372M | 396M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 15.5% | 13.0% | 12.1% | 11.9% | 14.2% | 16.7% | 10.5% | 10.2% | 11.4% | 10.0% | 11.6% |
| Net margin | 8.6% | 9.0% | 8.2% | 8.1% | 9.4% | 11.8% | 7.3% | 6.8% | 8.1% | 5.1% | 7.0% |
| FCF margin | 7.6% | 10.2% | 8.0% | 7.2% | 6.9% | 9.2% | 12.4% | 6.7% | 6.8% | 5.5% | 7.0% |
| ROIC | — | 18.2% | 15.6% | 15.2% | 18.3% | 21.6% | 13.1% | 12.7% | 15.8% | 10.4% | 14.3% |
| ROE | — | -112.6% | -230.5% | -295.5% | -203.9% | -745.5% | 656.3% | -124.8% | -76.5% | -32.6% | -39.6% |
Frequently asked questions
What is HCA Healthcare’s annual revenue?
$75.6B in fiscal 2025 and $78.7B over the twelve months to September 30, 2026.
How much profit does HCA Healthcare make?
Net income was $6.8B in fiscal 2025 (net margin 9.0%).
Is HCA Healthcare’s revenue growing?
Yes: revenue rose 7.1% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.